Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment
Hyperthyroidism is associated with several kinds of changes in the circulatory system, including alterations in blood volume. Arginine-vasopressin (AVP) is known to be one of the major factors regulating plasma volume. The present study was designed to evaluate the plasma AVP level in patients with...
Gespeichert in:
| Veröffentlicht in: | Medical science monitor 2001-05, Vol.7 (3), p.409-414 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 414 |
|---|---|
| container_issue | 3 |
| container_start_page | 409 |
| container_title | Medical science monitor |
| container_volume | 7 |
| creator | Marcisz, C Jonderko, G Kucharz, E J |
| description | Hyperthyroidism is associated with several kinds of changes in the circulatory system, including alterations in blood volume. Arginine-vasopressin (AVP) is known to be one of the major factors regulating plasma volume. The present study was designed to evaluate the plasma AVP level in patients with hyperthyroidism during treatment.
AVP was measured under basal conditions and after stimulation with a low-sodium diet and upright position. Seventy-four patients with hyperthyroidism and 37 controls were investigated. Measurements were taken before treatment, two weeks after pharmacological treatment, and after attaining euthyroid status. The following indices were determined: AVP, total and free thyroxin and triiodothyronine, thyrotropin, sodium, potassium, hematocrit, arterial blood pressure, cardiac index, and total peripheral resistance index. Plasma osmolality and changes in plasma volume were calculated indirectly.
Plasma AVP was higher in patients with hyperthyroidism before treatment. After normalization of thyroid status, the AVP level was similar to that of the controls. The application of a low-sodium diet and upright position resulted in a greater decrease in plasma volume than the controls. AVP correlated with thyroxin level and plasma osmolality in patients with hyperthyroidism.
Enhanced AVP level in patients with hyperthyroidism is suggested to be the result of alterations in plasma volume and is relatively independent of changes in plasma osmolality. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70888191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70888191</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-163fcc4b15e114fc4125ede4127d9bfd340ba9a23ec3f333d97951f3f0dbd1273</originalsourceid><addsrcrecordid>eNo1kM1OhDAURrvQOOPoK5iu3JH0UhhgaSb-JZO40a2k0FuogVJ7yxjeXhLH1TmLk2_xXbAtpDJLQIDYsGuiLyHSci_yK7YBkKtBsWWfh165DolPhvtB0ai4Cp111mFyUjT5gETW8QFPOPBVvIoWXST-Y2PP-8VjiP0SJqstjVzPwbqOx4Aqjmt2wy6NGghvz9yxj6fH98NLcnx7fj08HBMPaRoT2EvTtlkDOQJkps0gzVHjikJXjdEyE42qVCqxlUZKqauiysFII3Sj10ju2P3frg_T94wU69FSi8OgHE4z1YUoyxIqWMO7czg3I-raBzuqsNT_j8hfqi9eLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70888191</pqid></control><display><type>article</type><title>Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Marcisz, C ; Jonderko, G ; Kucharz, E J</creator><creatorcontrib>Marcisz, C ; Jonderko, G ; Kucharz, E J</creatorcontrib><description>Hyperthyroidism is associated with several kinds of changes in the circulatory system, including alterations in blood volume. Arginine-vasopressin (AVP) is known to be one of the major factors regulating plasma volume. The present study was designed to evaluate the plasma AVP level in patients with hyperthyroidism during treatment.
AVP was measured under basal conditions and after stimulation with a low-sodium diet and upright position. Seventy-four patients with hyperthyroidism and 37 controls were investigated. Measurements were taken before treatment, two weeks after pharmacological treatment, and after attaining euthyroid status. The following indices were determined: AVP, total and free thyroxin and triiodothyronine, thyrotropin, sodium, potassium, hematocrit, arterial blood pressure, cardiac index, and total peripheral resistance index. Plasma osmolality and changes in plasma volume were calculated indirectly.
Plasma AVP was higher in patients with hyperthyroidism before treatment. After normalization of thyroid status, the AVP level was similar to that of the controls. The application of a low-sodium diet and upright position resulted in a greater decrease in plasma volume than the controls. AVP correlated with thyroxin level and plasma osmolality in patients with hyperthyroidism.
Enhanced AVP level in patients with hyperthyroidism is suggested to be the result of alterations in plasma volume and is relatively independent of changes in plasma osmolality.</description><identifier>ISSN: 1234-1010</identifier><identifier>PMID: 11386017</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Arginine Vasopressin - blood ; Blood Flow Velocity ; Blood Pressure - drug effects ; Case-Control Studies ; Female ; Hematocrit ; Humans ; Hyperthyroidism - blood ; Male ; Middle Aged ; Potassium - blood ; Sodium - blood ; Thyrotropin - blood ; Thyroxine - blood ; Time Factors ; Triiodothyronine - blood</subject><ispartof>Medical science monitor, 2001-05, Vol.7 (3), p.409-414</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11386017$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marcisz, C</creatorcontrib><creatorcontrib>Jonderko, G</creatorcontrib><creatorcontrib>Kucharz, E J</creatorcontrib><title>Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment</title><title>Medical science monitor</title><addtitle>Med Sci Monit</addtitle><description>Hyperthyroidism is associated with several kinds of changes in the circulatory system, including alterations in blood volume. Arginine-vasopressin (AVP) is known to be one of the major factors regulating plasma volume. The present study was designed to evaluate the plasma AVP level in patients with hyperthyroidism during treatment.
AVP was measured under basal conditions and after stimulation with a low-sodium diet and upright position. Seventy-four patients with hyperthyroidism and 37 controls were investigated. Measurements were taken before treatment, two weeks after pharmacological treatment, and after attaining euthyroid status. The following indices were determined: AVP, total and free thyroxin and triiodothyronine, thyrotropin, sodium, potassium, hematocrit, arterial blood pressure, cardiac index, and total peripheral resistance index. Plasma osmolality and changes in plasma volume were calculated indirectly.
Plasma AVP was higher in patients with hyperthyroidism before treatment. After normalization of thyroid status, the AVP level was similar to that of the controls. The application of a low-sodium diet and upright position resulted in a greater decrease in plasma volume than the controls. AVP correlated with thyroxin level and plasma osmolality in patients with hyperthyroidism.
Enhanced AVP level in patients with hyperthyroidism is suggested to be the result of alterations in plasma volume and is relatively independent of changes in plasma osmolality.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Arginine Vasopressin - blood</subject><subject>Blood Flow Velocity</subject><subject>Blood Pressure - drug effects</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Hematocrit</subject><subject>Humans</subject><subject>Hyperthyroidism - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Potassium - blood</subject><subject>Sodium - blood</subject><subject>Thyrotropin - blood</subject><subject>Thyroxine - blood</subject><subject>Time Factors</subject><subject>Triiodothyronine - blood</subject><issn>1234-1010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kM1OhDAURrvQOOPoK5iu3JH0UhhgaSb-JZO40a2k0FuogVJ7yxjeXhLH1TmLk2_xXbAtpDJLQIDYsGuiLyHSci_yK7YBkKtBsWWfh165DolPhvtB0ai4Cp111mFyUjT5gETW8QFPOPBVvIoWXST-Y2PP-8VjiP0SJqstjVzPwbqOx4Aqjmt2wy6NGghvz9yxj6fH98NLcnx7fj08HBMPaRoT2EvTtlkDOQJkps0gzVHjikJXjdEyE42qVCqxlUZKqauiysFII3Sj10ju2P3frg_T94wU69FSi8OgHE4z1YUoyxIqWMO7czg3I-raBzuqsNT_j8hfqi9eLg</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Marcisz, C</creator><creator>Jonderko, G</creator><creator>Kucharz, E J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200105</creationdate><title>Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment</title><author>Marcisz, C ; Jonderko, G ; Kucharz, E J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-163fcc4b15e114fc4125ede4127d9bfd340ba9a23ec3f333d97951f3f0dbd1273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Arginine Vasopressin - blood</topic><topic>Blood Flow Velocity</topic><topic>Blood Pressure - drug effects</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Hematocrit</topic><topic>Humans</topic><topic>Hyperthyroidism - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Potassium - blood</topic><topic>Sodium - blood</topic><topic>Thyrotropin - blood</topic><topic>Thyroxine - blood</topic><topic>Time Factors</topic><topic>Triiodothyronine - blood</topic><toplevel>online_resources</toplevel><creatorcontrib>Marcisz, C</creatorcontrib><creatorcontrib>Jonderko, G</creatorcontrib><creatorcontrib>Kucharz, E J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Medical science monitor</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marcisz, C</au><au>Jonderko, G</au><au>Kucharz, E J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment</atitle><jtitle>Medical science monitor</jtitle><addtitle>Med Sci Monit</addtitle><date>2001-05</date><risdate>2001</risdate><volume>7</volume><issue>3</issue><spage>409</spage><epage>414</epage><pages>409-414</pages><issn>1234-1010</issn><abstract>Hyperthyroidism is associated with several kinds of changes in the circulatory system, including alterations in blood volume. Arginine-vasopressin (AVP) is known to be one of the major factors regulating plasma volume. The present study was designed to evaluate the plasma AVP level in patients with hyperthyroidism during treatment.
AVP was measured under basal conditions and after stimulation with a low-sodium diet and upright position. Seventy-four patients with hyperthyroidism and 37 controls were investigated. Measurements were taken before treatment, two weeks after pharmacological treatment, and after attaining euthyroid status. The following indices were determined: AVP, total and free thyroxin and triiodothyronine, thyrotropin, sodium, potassium, hematocrit, arterial blood pressure, cardiac index, and total peripheral resistance index. Plasma osmolality and changes in plasma volume were calculated indirectly.
Plasma AVP was higher in patients with hyperthyroidism before treatment. After normalization of thyroid status, the AVP level was similar to that of the controls. The application of a low-sodium diet and upright position resulted in a greater decrease in plasma volume than the controls. AVP correlated with thyroxin level and plasma osmolality in patients with hyperthyroidism.
Enhanced AVP level in patients with hyperthyroidism is suggested to be the result of alterations in plasma volume and is relatively independent of changes in plasma osmolality.</abstract><cop>United States</cop><pmid>11386017</pmid><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1234-1010 |
| ispartof | Medical science monitor, 2001-05, Vol.7 (3), p.409-414 |
| issn | 1234-1010 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70888191 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adolescent Adult Arginine Vasopressin - blood Blood Flow Velocity Blood Pressure - drug effects Case-Control Studies Female Hematocrit Humans Hyperthyroidism - blood Male Middle Aged Potassium - blood Sodium - blood Thyrotropin - blood Thyroxine - blood Time Factors Triiodothyronine - blood |
| title | Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A08%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20of%20plasma%20arginine-vasopressin%20level%20in%20patients%20with%20hyperthyroidism%20during%20treatment&rft.jtitle=Medical%20science%20monitor&rft.au=Marcisz,%20C&rft.date=2001-05&rft.volume=7&rft.issue=3&rft.spage=409&rft.epage=414&rft.pages=409-414&rft.issn=1234-1010&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E70888191%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70888191&rft_id=info:pmid/11386017&rfr_iscdi=true |